kappa-Opioid receptor activates an inwardly rectifying K+ channel by a G protein-linked mechanism: coexpression in Xenopus oocytes

Mol Pharmacol. 1995 May;47(5):1035-40.

Abstract

cRNAs encoding the kappa-opioid receptor and an inwardly rectifying, G protein-coupled, K+ channel were coinjected into Xenopus oocytes. The effects of kappa-opioid receptor agonists and antagonists on the membrane currents in these oocytes were studied using the two-electrode voltage-clamp technique. The kappa-opioid receptor agonists U69593 and dynorphin A induced a concentration-dependent inward current (EC50 of approximately 0.3 microM and approximately 30 nM, respectively) after coinjection of both cRNAs, whereas the mu-opioid receptor agonist [D-Ala2,N-MePhe4,Gly5-ol]enkephalin (10 microM) and the delta-opioid receptor agonist [D-Pen2,5]enkephalin (1 microM) had no effect. The agonist-induced inward current was reversible upon washing out of the agonists and was inhibited in the presence of the K+ channel blocker Ba2+ (0.1 mM). The specific kappa-opioid receptor antagonist norbinaltorphimine (0.1 microM) and the nonspecific opioid receptor antagonist naloxone (1 microM) abolished the agonist-induced currents. Furthermore, the agonist-induced currents exhibited rapid desensitization in the continuous presence of the agonists or after repeated application. Preincubation of the coinjected oocytes with pertussis toxin (400 ng/ml for 3 days of 1.5 microgram/ml for 24 hr) abolished most of the agonist-induced activation of the inwardly rectifying K+ current. We therefore conclude that specific stimulation of the kappa-opioid receptor can activate the inwardly rectifying K+ channel through a pertussis toxin-sensitive G protein.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Benzeneacetamides*
  • Cloning, Molecular
  • Dynorphins / pharmacology
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Enkephalin, D-Penicillamine (2,5)-
  • Enkephalins / pharmacology
  • Female
  • GTP-Binding Proteins / metabolism*
  • Gene Expression / drug effects
  • In Vitro Techniques
  • Mice
  • Naloxone / pharmacology
  • Naltrexone / analogs & derivatives
  • Naltrexone / pharmacology
  • Oocytes / metabolism
  • Pertussis Toxin
  • Potassium Channels / drug effects
  • Potassium Channels / genetics
  • Potassium Channels / metabolism*
  • Pyrrolidines / pharmacology
  • RNA, Complementary / genetics
  • Receptors, Opioid, kappa / drug effects
  • Receptors, Opioid, kappa / genetics
  • Receptors, Opioid, kappa / metabolism*
  • Virulence Factors, Bordetella / pharmacology
  • Xenopus

Substances

  • Benzeneacetamides
  • Enkephalins
  • Potassium Channels
  • Pyrrolidines
  • RNA, Complementary
  • Receptors, Opioid, kappa
  • Virulence Factors, Bordetella
  • Enkephalin, Ala(2)-MePhe(4)-Gly(5)-
  • Naloxone
  • norbinaltorphimine
  • Naltrexone
  • Dynorphins
  • Enkephalin, D-Penicillamine (2,5)-
  • Pertussis Toxin
  • GTP-Binding Proteins
  • U 69593